How much is the current vaccine R&D pipeline worth? Published 9th November 2010.
VacZine Analytics has estimated the commercial value of the current vaccine R&D pipeline. This article will introduce key findings of the analysis and discuss methodology along with assumptions applied.
PREMIUMThis article is available only on a "pay per view" basis or to purchasers of VaccineSTATS: Vaccine R&D pipeline review "premium access" (CAT No: VAVS016)